Sexual Adverse Effects and Erectile Dysfunction During Buprenorphine/Naloxone Combination Treatment for Opioid Use Disorders.  Bestepe EE, Tunali N, Sarıdoğan GE.  Neuropsychiatr Dis Treat. 2020 Nov 12;16:2695-2705. doi: 10.2147/NDT.S276…

Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study.  Ling W, Nadipelli VR, Aldridge AP, Ronquest NA, Solem CT, Chilcoat H, Albright V…

How do individuals fare long-term after receiving long-acting, injectable formulations of buprenorphine for opioid use disorder? Evidence has mounted regarding the short-term effectiveness of long-acting buprenorphine formulations for opioid use di…

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine.  Blazes CK, Morrow JD.  Front Psychiatry. 2020 Sep 11;11:549272. doi: 10.3389/fpsyt.2020.549272. PMID: 33061915; PMCID: PMC7517938. https://www.ncbi.nlm.nih.gov/pmc/artic…

Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.  Tran PN, Sheng J, Randolph AL, Baron CA, Thiebaud N, Ren M, et al. (2020)  PLoS ONE 15(11): e0241362. doi.org/10.1371/journal.pone.0241362…

Prescribing Buprenorphine for Opioid Use Disorders in the ED: A Review of Best Practices, Barriers, and Future Directions.  Cao SS, Dunham SI, Simpson SA.  Open Access Emerg Med. 2020 Oct 14;12:261-274. doi: 10.2147/OAEM.S267416. PMID: 3…